Bay Area's Menlo Therapeutics Files for $98M IPO Post author:Sam Post published:December 28, 2017 Post category:BioPharma Menlo Therapeutics filed on Thursday with the SEC to raise up to $98M in an IPO. Source: BioSpace You Might Also Like Top 3 Takeover Targets for Pfizer January 22, 2018 Blue Earth Diagnostics Receives Positive Opinion For Axumin (Fluciclovine (18F)) For PET Imaging Of Recurrent Prostate Cancer March 23, 2017 Finally Some Good News as the FDA Lifts Hold on Sanofi, Alnylam's Fitusiran December 14, 2017
Blue Earth Diagnostics Receives Positive Opinion For Axumin (Fluciclovine (18F)) For PET Imaging Of Recurrent Prostate Cancer March 23, 2017
